Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 71,738 shares at $62.58 ($4.5M) on 2020-04-15, disclosed to the SEC on 2020-04-15.
Seasonal sale ($4.5M) by Chairman — this insider has traded EBS in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.25 | 17,071 | $1.1M | 23.7% |
| 2 | $62.25 | 17,071 | $1.1M | 23.7% |
| 3 | $62.99 | 6,261 | $394K | 8.8% |
| 4 | $62.99 | 6,261 | $394K | 8.8% |
| 5 | $62.58 | 12,537 | $785K | 17.5% |
| 6 | $62.58 | 12,537 |
| $785K |
| 17.5% |
| Total | $62.49 avg | 71,738 | $4.5M | 100% |
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |